
============================================================
                    AKTIENANALYSE: GILD                     
============================================================
Firmendaten werden abgerufen...
+-------------+------------------------------+------------------------------+
| Kategorie   | Details                      | ErlÃ¤uterung                  |
+=============+==============================+==============================+
| Unternehmen | Gilead Sciences, Inc.        | Name des Unternehmens        |
+-------------+------------------------------+------------------------------+
| Sektor      | Healthcare                   | Wirtschaftssektor            |
+-------------+------------------------------+------------------------------+
| Branche     | Drug Manufacturers - General | Industrie oder GeschÃ¤ftsfeld |
+-------------+------------------------------+------------------------------+
| Land        | United States                | Herkunftsland                |
+-------------+------------------------------+------------------------------+

Kurzbeschreibung: Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company ...

Historische Daten werden abgerufen...
Historische Daten erfolgreich abgerufen.

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
            KURSVERLAUF VISUALISIERUNG            
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
ASCII-ART KURSVERLAUF (Letzte 90 Tage)
Hoch: 115.77 | Tief: 94.80
--------------------------------------------------
                 *                                                                        
             * ** *                                                                       
            * *    *** *         *  *                                           **  *     
        ****          * *      ** **                                      **   *  *  **   
      **                 *   **      *                              ** ***  ***    *   ***
  *  *                    ***         * *  ***  *** * *            *  *                   
 * **                                  *  *   **   * * ***    *                           
                                         *                     * **                       
                                                          ***   *                         
*                                                            *                            
--------------------------------------------------
Datenpunkte: Jeder * reprÃ¤sentiert einen Tag

PERFORMANCE VERGLEICH (Letzte 252 Handelstage)
--------------------------------------------------
GILD                : +77.35%
S&P500              : +8.76%
--------------------------------------------------
GILD hat den S&P500 outperformt!

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                TECHNISCHE ANALYSE                
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+----------------+---------+---------------------------------+
| Kategorie      | Wert    | ErlÃ¤uterung                     |
+================+=========+=================================+
| Aktueller Kurs | $108.50 | Letzter Schlusskurs             |
+----------------+---------+---------------------------------+
| TagesÃ¤nderung  | 0.5%    | Prozentuale Ã„nderung zum Vortag |
+----------------+---------+---------------------------------+
| Volumen        | N/A     | Gehandeltes Volumen             |
+----------------+---------+---------------------------------+
| MA(20)         | $109.06 | 20-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(50)         | $105.30 | 50-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(200)        | $96.35  | 200-Tage-Durchschnitt           |
+----------------+---------+---------------------------------+
| RSI(14)        | 47.7    | Relative Strength Index         |
+----------------+---------+---------------------------------+
| 52W Hoch       | $118.28 | 52-Wochen-HÃ¶chstkurs            |
+----------------+---------+---------------------------------+
| 52W Tief       | $59.40  | 52-Wochen-Tiefstkurs            |
+----------------+---------+---------------------------------+
| VolatilitÃ¤t    | 24.9%   | JÃ¤hrliche VolatilitÃ¤t           |
+----------------+---------+---------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
             FUNDAMENTALE KENNZAHLEN              
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+----------------------+---------------------+-----------------------------------------+
| Kategorie            | Wert                | ErlÃ¤uterung                             |
+======================+=====================+=========================================+
| Marktkapitalisierung | $134,966,403,072.00 | Gesamtwert der Aktien                   |
+----------------------+---------------------+-----------------------------------------+
| KGV (P/E)            | 22.79               | Kurs-Gewinn-VerhÃ¤ltnis                  |
+----------------------+---------------------+-----------------------------------------+
| Forward P/E          | 14.60               | Erwartetes KGV                          |
+----------------------+---------------------+-----------------------------------------+
| Dividendenrendite    | 2.91%               | Dividende im VerhÃ¤ltnis zum Kurs        |
+----------------------+---------------------+-----------------------------------------+
| Verschuldungsgrad    | 130.79              | VerhÃ¤ltnis von Schulden zu Eigenkapital |
+----------------------+---------------------+-----------------------------------------+

Bewertung der fundamentalen Kennzahlen:
- pe_ratio: Durchschnittlich
- dividend_yield: Gut (hohe Rendite)
- debt_to_equity: Schlecht (hohe Verschuldung)

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
               ANALYSTENSCHÃ„TZUNGEN               
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+--------------------+---------+------------------------------+
| Kategorie          | Wert    | ErlÃ¤uterung                  |
+====================+=========+==============================+
| Analysten-Kursziel | $116.77 | Durchschnittliches Kursziel  |
+--------------------+---------+------------------------------+
| Upside-Potenzial   | 7.6%    | Potenzial fÃ¼r Kurssteigerung |
+--------------------+---------+------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
            DCF SCHÃ„TZUNG & SZENARIEN             
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+--------------------------+------------+----------+---------------------------------------------+
| Szenario                 | DCF Wert   | Upside   | Annahmen                                    |
+==========================+============+==========+=============================================+
| Basis-Szenario           | $128.63    | 18.6%    | Annahmen: Wachstum 0.1%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+
| Optimistisches Szenario  | $163.65    | 50.8%    | Annahmen: Wachstum 0.1%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+
| Pessimistisches Szenario | $91.90     | -15.3%   | Annahmen: Wachstum 0.0%, Diskontierung 0.1% |
+--------------------------+------------+----------+---------------------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
               SENSITIVITÃ„TSANALYSE               
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-----------------+----------------------+------------+
| Wachstumsrate   | Diskontierungsrate   | DCF Wert   |
+=================+======================+============+
| Wachstum 0.0%   | Diskontierung 0.1%   | $91.90     |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | $118.16    |
+-----------------+----------------------+------------+
| Wachstum 0.0%   | Diskontierung 0.1%   | $137.85    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $99.78     |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $128.63    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $150.29    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $108.22    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $139.88    |
+-----------------+----------------------+------------+
| Wachstum 0.1%   | Diskontierung 0.1%   | $163.65    |
+-----------------+----------------------+------------+

==============================
Gesamtbewertung abgeschlossen 
==============================

+-------------+------------------------------+------------------------------+
| Kategorie   | Details                      | ErlÃ¤uterung                  |
+=============+==============================+==============================+
| Unternehmen | Gilead Sciences, Inc.        | Name des Unternehmens        |
+-------------+------------------------------+------------------------------+
| Sektor      | Healthcare                   | Wirtschaftssektor            |
+-------------+------------------------------+------------------------------+
| Branche     | Drug Manufacturers - General | Industrie oder GeschÃ¤ftsfeld |
+-------------+------------------------------+------------------------------+
| Land        | United States                | Herkunftsland                |
+-------------+------------------------------+------------------------------+
+----------------+---------+---------------------------------+
| Kategorie      | Wert    | ErlÃ¤uterung                     |
+================+=========+=================================+
| Aktueller Kurs | $108.50 | Letzter Schlusskurs             |
+----------------+---------+---------------------------------+
| TagesÃ¤nderung  | 0.5%    | Prozentuale Ã„nderung zum Vortag |
+----------------+---------+---------------------------------+
| Volumen        | N/A     | Gehandeltes Volumen             |
+----------------+---------+---------------------------------+
| MA(20)         | $109.06 | 20-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(50)         | $105.30 | 50-Tage-Durchschnitt            |
+----------------+---------+---------------------------------+
| MA(200)        | $96.35  | 200-Tage-Durchschnitt           |
+----------------+---------+---------------------------------+
| RSI(14)        | 47.7    | Relative Strength Index         |
+----------------+---------+---------------------------------+
| 52W Hoch       | $118.28 | 52-Wochen-HÃ¶chstkurs            |
+----------------+---------+---------------------------------+
| 52W Tief       | $59.40  | 52-Wochen-Tiefstkurs            |
+----------------+---------+---------------------------------+
| VolatilitÃ¤t    | 24.9%   | JÃ¤hrliche VolatilitÃ¤t           |
+----------------+---------+---------------------------------+
+----------------------+---------------------+-----------------------------------------+
| Kategorie            | Wert                | ErlÃ¤uterung                             |
+======================+=====================+=========================================+
| Marktkapitalisierung | $134,966,403,072.00 | Gesamtwert der Aktien                   |
+----------------------+---------------------+-----------------------------------------+
| KGV (P/E)            | 22.79               | Kurs-Gewinn-VerhÃ¤ltnis                  |
+----------------------+---------------------+-----------------------------------------+
| Forward P/E          | 14.60               | Erwartetes KGV                          |
+----------------------+---------------------+-----------------------------------------+
| Dividendenrendite    | 2.91%               | Dividende im VerhÃ¤ltnis zum Kurs        |
+----------------------+---------------------+-----------------------------------------+
| Verschuldungsgrad    | 130.79              | VerhÃ¤ltnis von Schulden zu Eigenkapital |
+----------------------+---------------------+-----------------------------------------+
+--------------------+---------+------------------------------+
| Kategorie          | Wert    | ErlÃ¤uterung                  |
+====================+=========+==============================+
| Analysten-Kursziel | $116.77 | Durchschnittliches Kursziel  |
+--------------------+---------+------------------------------+
| Upside-Potenzial   | 7.6%    | Potenzial fÃ¼r Kurssteigerung |
+--------------------+---------+------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
           AKTIENSTRATEGIE & EMPFEHLUNG           
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| Kategorie         | Wert                                                                  | ErlÃ¤uterung                                |
+===================+=======================================================================+============================================+
| Kategorie         | Wert                                                                  | ErlÃ¤uterung                                |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| Gesamtempfehlung  | ðŸŸ¢ Kaufen                                                              | Zusammenfassende Bewertung der Aktie.      |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| StÃ¤rken           | Hohe Dividendenrendite                                                | Positive Aspekte der Analyse.              |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| SchwÃ¤chen/Risiken | Hoher Verschuldungsgrad                                               | Negative Aspekte oder potenzielle Risiken. |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| BegrÃ¼ndung        | Forward P/E: 14.60, Dividende: 291.00%, DCF: 128.63374255311285 (EUR) | GrÃ¼nde fÃ¼r die Bewertung.                  |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+
| Kaufzone          | 128.63374255311285 (EUR)                                              | Preisbereich fÃ¼r den Einstieg.             |
+-------------------+-----------------------------------------------------------------------+--------------------------------------------+

â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
                DIVIDENDENWACHSTUM                
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
+---------------+-----------------+
| Kategorie     | Wert            |
+===============+=================+
| Jahr          | Dividende (EUR) |
+---------------+-----------------+
| 2016          | $1.84           |
+---------------+-----------------+
| 2017          | $2.08           |
+---------------+-----------------+
| 2018          | $2.28           |
+---------------+-----------------+
| 2019          | $2.52           |
+---------------+-----------------+
| 2020          | $2.72           |
+---------------+-----------------+
| 2021          | $2.84           |
+---------------+-----------------+
| 2022          | $2.92           |
+---------------+-----------------+
| 2023          | $3.00           |
+---------------+-----------------+
| 2024          | $3.08           |
+---------------+-----------------+
| 2025          | $1.58           |
+---------------+-----------------+
| Wachstumsrate | -1.68%          |
+---------------+-----------------+
Bewertung: Volatiles Wachstum mit durchschnittlich -1.68% pro Jahr.
